Skip to main content

Table 3 Summary of sample information

From: Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs

  Pancreatic cancer (n = 24) Biliary tract cancer (n = 10) Healthy control (n = 21)
Age, year, mean ± SD 62.8 ± 11.1 62.8 ± 7.8 43.9 ± 11.8
Sex (%)
 Male 11 (45.8%) 7 (70.0%) 15 (71.4%)
 Female 13 (54.2%) 3 (30.0%) 6 (28.6%)
 Diabetes (%) 8 (33.3%) 5 (50.0%) 1 (4.8%)
 Hypertension (%) 12 (50.0%) 3 (30.0%) 1 (4.8%)
 Smoking (%) 4 (16.7%) 5 (50%) 0 (0.0%)
 BMI, kg/m2, mean ± SD 21.7 ± 2.9 23.2 ± 3.9 23.8 ± 3.8
 CA19–9, U/ml, mean ± SD 3444.5 ± 6543.2 807.1 ± 1457.9 7.9 ± 6.9
 Tumor size, mm, mean ± SD 31.2 ± 11.1 34.2 ± 26.5 n/a
Stage (%)
 I 2 (8.3%) 2 (20.0%) n/a
 II 9 (37.5%) 3 (60.0%) n/a
 III 0 (0.0%) 1 (10.0%) n/a
 IV 13 (54.2%) 4 (40.0%) n/a
 Recurrence after surgery (%) 4/11 (36.4%) 7/8 (87.5%) n/a
 DFS, median (range) 10.5 (3.1–46.8) 15.9 (2.1–44.1) n/a
 OS, month, median (range) 15.2 (3.7–56.8) 21.7 (2.8–44.7) n/a
  1. Abbreviations: SD, standard deviation; BMI, body mass index; DFS, disease-free survival; OS, overall survival